Table 1.
GFP-LC3 |
YFP-LAMP |
LysoTracker Red |
||||
---|---|---|---|---|---|---|
Control | RM | Control | RM | Control | RM | |
Total vesicles | 107 | 64 | 82 | 84 | 62 | 77 |
Total movements | 3648 | 1074 | 1975 | 3139 | 2039 | 3257 |
Mean retrograde velocity (μm/s) | 0.32 ± 0.07 | 0.33 ± 0.02 | 0.54 ± 0.05 | 0.47 ± 0.06 | 0.29 ± 0.03 | 0.25 ± 0.02 |
Net anterograde vesicles | 3 | 2 | 46 | 48 | 31 | 42 |
Net retrograde vesicles | 95 | 57 | 32 | 31 | 29 | 30 |
Stationary vesicles | 8 | 5 | 4 | 5 | 2 | 5 |
Axonal transport of GFP-LC3, YFP-LAMP, and LysoTracker Red vesicles under normal conditions (control) or after rapamycin (RM) treatment (10 nm, 5 h). RM does not significantly alter motility, movement direction, or velocity for GFP-LC3, YFP-LAMP, or LysoTracker Red vesicles.